Imexpharm Corp (IMP) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.044x

Based on the latest financial reports, Imexpharm Corp (IMP) has a cash flow conversion efficiency ratio of 0.044x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫103.49 Billion ≈ $3.93 Million USD) by net assets (₫2.38 Trillion ≈ $90.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review IMP financial flexibility index to assess the company's free cash flow relative to its total liabilities.

Imexpharm Corp - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Imexpharm Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see IMP stock market capitalisation for the company's overall valuation and market capitalisation.

Imexpharm Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imexpharm Corp ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
HMH Holding Inc. Class A Common Stock NASDAQ:HMH	0.010x
AME Elite Consortium Bhd KLSE:5293	-0.137x
SILICOM LTD IS-01 F:S1L	N/A
DCX Systems Limited NSE:DCXINDIA	0.002x
Ascom Holding AG SW:ASCN	0.143x
Akmerkez Gayrimenkul Yatirim Ortakligi AS IS:AKMGY	0.014x
Prosafe SE OL:PRS	-0.021x
Suheung Capsul KO:008490	0.017x

Annual Cash Flow Conversion Efficiency for Imexpharm Corp (2019–2025)

The table below shows the annual cash flow conversion efficiency of Imexpharm Corp from 2019 to 2025. View Imexpharm Corp stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₫2.31 Trillion ≈ $87.63 Million	₫54.17 Billion ≈ $2.06 Million	0.023x	-76.29%
2024-12-31	₫2.18 Trillion ≈ $82.95 Million	₫216.27 Billion ≈ $8.22 Million	0.099x	+610.25%
2023-12-31	₫2.08 Trillion ≈ $79.20 Million	₫-40.47 Billion ≈ $-1.54 Million	-0.019x	-109.71%
2022-12-31	₫1.89 Trillion ≈ $71.98 Million	₫378.60 Billion ≈ $14.38 Million	0.200x	+52.68%
2021-12-31	₫1.79 Trillion ≈ $68.18 Million	₫234.88 Billion ≈ $8.92 Million	0.131x	+209.64%
2020-12-31	₫1.73 Trillion ≈ $65.75 Million	₫73.15 Billion ≈ $2.78 Million	0.042x	-1.04%
2019-12-31	₫1.56 Trillion ≈ $59.23 Million	₫66.59 Billion ≈ $2.53 Million	0.043x	--

About Imexpharm Corp

VN:IMP Vietnam Drug Manufacturers - Specialty & Generic

Market Cap

$215.62 Million

₫5.68 Trillion VND

Market Cap Rank

#16310 Global

#90 in Vietnam

Share Price

₫36850.00

Change (1 day)

+0.41%

52-Week Range

₫35000.00 - ₫56700.00

All Time High

₫97000.00